Skip to search formSkip to main contentSkip to account menu

Ovarian Carcinoma

Known as: ovarian ca, cancer ovary, ovarian cancer 
National Institutes of Health

Related topics

Related topics

10 relations
Basal Cell Nevus SyndromeHamartoma Syndrome, MultipleMalignant Neoplasmsovarian carcinosarcoma

Narrower (3)

Epithelial ovarian cancerMalignant Brenner Tumorovarian adenocarcinoma

Broader (3)

Malignant neoplasm of ovaryNeoplasm, uncertain whether benign or malignantovarian neoplasm

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Validation of tissue microarray technology in ovarian carcinoma
High-throughput tissue microarray allows many clinical specimens to be analyzed simultaneously on a single slide. One potential… 
Highly Cited
2000
Highly Cited
2000
Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.
The DNA base excision repair pathway is responsible for the repair of alkylation and oxidative DNA damage. A crucial step in the… 
Highly Cited
2000
Highly Cited
2000
Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis.
As the rate of gene discovery accelerates, more efficient methods are needed to analyze genes in human tissues. To assess the… 
Highly Cited
1996
Highly Cited
1996
Expression and localization of alpha v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma.
In an extension of a previous in vitro study [Carreiras et al., Int. J. Cancer 63, 530-536 (1995)] and in an effort to understand… 
Highly Cited
1996
Highly Cited
1996
An abundance of p53 null mutations in ovarian carcinoma.
Ovarian cancers from 64 midwestern US women were screened for p53 dysfunction both by immunohistochemical staining (IHCS) and… 
Highly Cited
1995
Highly Cited
1995
Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu.
The HER-2/neu proto-oncogene is frequently amplified or overexpressed in many different types of human cancers, a phenomenon that… 
Highly Cited
1994
Highly Cited
1994
Incremental angiogenesis assessed by color doppler ultrasound in the tumorigenesis of ovarian neoplasms
Background. The crucial role of angiogenesis in tumor behavior has been studied extensively in vitro. The authors assessed the in… 
Highly Cited
1993
Highly Cited
1993
Antibody‐induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c‐erbb‐2 (her‐2/neu) gene product p185
Over‐expression of the c‐erbB‐2 (HER‐2/neu) gene product p185 occurs in 30% of breast and ovarian cancers. The p185 protein might… 
Highly Cited
1990
Highly Cited
1990
Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
Recently, tumor-specific allele loss has been shown to be an important characteristic of some tumors. When such loss includes one… 
Highly Cited
1970
Highly Cited
1970
Chemotherapy in the treatment of cancer of the ovary
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)